in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Granules India acquires API manufacturer, opens API research facility
November 4, 2013 | Deepti Ramesh
Granules India (Hyderabad, India), a producer of active pharmaceutical ingredients (APIs), intermediates, and formulations, says it has signed an agreement to acquire API manufacturer Auctus Pharma (Hyderabad). The purchase price is about 1.2 billion Indian rupees ($19 million), Granules tells CW. The acquisition is expected to be completed within the next three to six months. The product portfolio of Auctus includes 12 APIs—in several therapeutic categories, such as antihistaminic, antihypertensive, antithrombotic, and anticonvulsant—and key...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee